BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6343259)

  • 1. A comparison of once and twice daily atenolol for angina pectoris.
    Boyle RM; Bray CL; Naqvi N; Croxson RS; Cruickshank JM
    Int J Cardiol; 1983 Apr; 3(1):25-35. PubMed ID: 6343259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.
    Jackson G; Harry JD; Robinson C; Kitson D; Jewitt DE
    Br Heart J; 1978 Sep; 40(9):998-1004. PubMed ID: 101223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved exercise performance following single daily dose of atenolol in stable angina.
    Balu V; Zaki Masud AR; Dean DC; Naughton J
    Int J Cardiol; 1983 Apr; 3(1):15-24. PubMed ID: 6852987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris.
    Maltz MB; Dymond DS; Nathan AW; Camm AJ
    Eur Heart J; 1987 Dec; 8 Suppl M():37-42. PubMed ID: 2967184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once daily atenolol (Tenormine) in the treatment of angina pectoris. Observations on clinical efficacy, pharmacokinetics and pharmacodynamics.
    Majid PA; van der Vijgh WJ; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
    Eur J Cardiol; 1979 Jun; 9(6):419-35. PubMed ID: 381009
    [No Abstract]   [Full Text] [Related]  

  • 6. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
    Antalóczy Z; Kekes E
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
    Bowles MJ; Smith L; Glover DR
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():85-90. PubMed ID: 2196372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atenolol on treadmill performance in patients with angina pectoris.
    Kritzer G; Warr TA; Strong ML; Froelicher VF
    Clin Pharm; 1983; 2(3):236-42. PubMed ID: 6349909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atenolol and celiprolol for stable angina pectoris.
    McLenachan JM; Findlay IN; Henderson E; Wilson JT; Dargie HJ
    Am J Cardiol; 1988 Feb; 61(5):52C. PubMed ID: 2893533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atenolol once daily in angina.
    Mäkynen P; Karhumäki L; Seppänen S
    Ann Clin Res; 1979 Apr; 11(2):53-7. PubMed ID: 110212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atenolol with and without nifedipine in the treatment of angina pectoris. Preliminary report.
    Sandberg M; Foale RA
    Drugs; 1988; 35 Suppl 4():51-5. PubMed ID: 3132360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the duration of action of atenolol and nadolol for treatment of angina pectoris.
    Kostis JB
    Am J Cardiol; 1988 Dec; 62(17):1171-5. PubMed ID: 3057850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
    Salonen JT; Taskinen E; Salonen R; Seppänen K; Venäläinen J; Rauramaa R
    Am J Cardiol; 1986 Nov; 58(12):35E-40E. PubMed ID: 2878600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bevantolol and atenolol in chronic stable angina.
    Rodrigues EA; Lawrence JD; Dasgupta P; Hains AD; Lahiri A; Wilkinson PR; Raftery EB
    Am J Cardiol; 1988 Jun; 61(15):1204-9. PubMed ID: 2897780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris.
    Schwartz JB; Jackson G; Kates RE; Harrison DC
    Am Heart J; 1981 Apr; 101(4):380-5. PubMed ID: 6111212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA).
    de Muinck ED; Buchner-Moell D; van de Ven LL; Lie KI
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):870-5. PubMed ID: 1376806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol.
    De Backer GG; Derese A
    Am Heart J; 1985 Mar; 109(3 Pt 2):678-81. PubMed ID: 3883735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atenolol in the treatment of angina pectoris].
    Bachmann M; Raeber E; Burckhardt D; Schwytzer F; Münch U; Kappenberger L; Nager F
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1857-60. PubMed ID: 531563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atenolol: once-daily cardioselective beta blockade for angina pectoris.
    Jackson G; Schwartz J; Kates RE; Winchester M; Harrison DC
    Circulation; 1980 Mar; 61(3):555-60. PubMed ID: 6243518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.